Frisoni, G.B.; Annoni, J.-M.; Becker, S.; Brockmann, T.; Buerge, M.; Démonet, J.-F.; Georgescu, D.; Gietl, A.; Hemmeter, U.; Klöppel, S.;
et al. Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders. Clin. Transl. Neurosci. 2021, 5, 14.
https://doi.org/10.3390/ctn5020014
AMA Style
Frisoni GB, Annoni J-M, Becker S, Brockmann T, Buerge M, Démonet J-F, Georgescu D, Gietl A, Hemmeter U, Klöppel S,
et al. Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders. Clinical and Translational Neuroscience. 2021; 5(2):14.
https://doi.org/10.3390/ctn5020014
Chicago/Turabian Style
Frisoni, Giovanni B, Jean-Marie Annoni, Stefanie Becker, Tim Brockmann, Markus Buerge, Jean-François Démonet, Dan Georgescu, Anton Gietl, Ulrich Hemmeter, Stefan Klöppel,
and et al. 2021. "Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders" Clinical and Translational Neuroscience 5, no. 2: 14.
https://doi.org/10.3390/ctn5020014
APA Style
Frisoni, G. B., Annoni, J.-M., Becker, S., Brockmann, T., Buerge, M., Démonet, J.-F., Georgescu, D., Gietl, A., Hemmeter, U., Klöppel, S., Leyhe, T., Monsch, A. U., Rogantini, F., Roulet Schwab, D., Savaskan, E., Schaller, K., von Gunten, A., & Gold, G.
(2021). Position Statement on Anti-Dementia Medication for Alzheimer’s Disease by Swiss Stakeholders. Clinical and Translational Neuroscience, 5(2), 14.
https://doi.org/10.3390/ctn5020014
